IRF5 and low grade glioma: In low-grade gliomas (LGG), elevated mRNA levels of TGFB2 emerged as a significant negative prognostic marker, particularly when coupled with the activation of interferon-gamma receptor signaling via Interferon Regulatory Factor 5 (IRF5) and the increased expression of the immune checkpoint molecule B7-H3 [30].